Cancer neuroscience and glioma (2025)

2025-02-04T13:58:50+01:00

In recent years, it has been increasingly recognized that tumor growth relies not only on support from the surrounding microenvironment but also on the tumors capacity to adapt to - and actively manipulate - its niche. While targeting angiogenesis and modulating the local immune environment have been explored as therapeutic approaches, these strategies [...]

Cancer neuroscience and glioma (2025)2025-02-04T13:58:50+01:00

Double Bond aims at adaptive design for SI-053 Phase I

2018-11-20T23:39:15+01:00

Double Bond aims at adaptive design for SI-053 Phase I FRI, MAY 04, 2018 10:19 CET Double Bond Pharmaceutical (DBP) has signed a service contract with Cytel Inc, a leading provider of clinical research services and software, to develop an adaptive model-based study design for [...]

Double Bond aims at adaptive design for SI-053 Phase I2018-11-20T23:39:15+01:00
Go to Top